Table 4.
Infants | Toddlers | Children | Adolescents | Adults | The elderly | |
---|---|---|---|---|---|---|
(12 weeks–11 months) | (12–35 months) | (3–9 years) | (10–17 years) | (18–64 years) | (≥ 65 years) | |
Maximum level exposure assessment scenario | ||||||
Mean | 122.8–445.0 | 224.0–711.7 | 114.0–517.1 | 61.1–355.7 | 48.5–273.1 | 56.3–290.8 |
95th percentile | 247.1–894.2 | 424.2–1021.9 | 228.3–1,182.8 | 106.1–741.6 | 96.6–542.5 | 110.3–586.3 |
Refined estimated exposure assessment scenario | ||||||
Brand‐loyal scenario | ||||||
Mean | 13.7–335.8 | 109.9–449.3 | 48.5–329.7 | 24.1–215.0 | 18.6–154.8 | 19.7–159.9 |
95th percentile | 45.1–812.3 | 258.7–663.2 | 110.4–865.0 | 46.7–562.8 | 38.8–380.2 | 38.2–392.9 |
Non‐brand‐loyal scenario | ||||||
Mean | 6.0–311.6 | 24.6–93.1 | 23.7–54.4 | 12.2–31.4 | 7.3–20.6 | 6.9–19.8 |
95th percentile | 23.4–609.8 | 63.5–280.5 | 47.1–122.5 | 26.8–67.6 | 15.3–41.5 | 14.7–44.1 |